Search Results 501-510 of 16290 for pharmacogenetics
Hereditary hemochromatosis is an inherited disease that makes your body absorb more iron than it needs, leading to iron overload. Over time, excess iron can ...
The Mukhopadhyay Tumor Angiogenesis and Vascular Biology Lab at Mayo Clinic is developing inhibitory peptides and small molecules to target GIPC and its ...
About this study · characterize their risk for developing T1D and identify subjects eligible for prevention trials; · describe the pathogenic evolution of T1D; ...
The purpose of this study is to determine the efficacy of repeat dosing with multiple dose levels of bimagrumab on patient physical function, skeletal muscle ...
The investigators propose here to use both targeted and non-targeted metabolomic approach to identify pathways associated with metformin's effect on insulin ...
The Pharmacology Shared Resource provides preclinical and clinical pharmacokinetic, pharmacodynamic and pharmacogenetic expertise, methodologies and ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Mayo Clinic has been able to diagnose approximately 30 percent of patients with unexplained genetic disorders. The Genomic Odyssey Board would like to close the ...
Intro: It could be your mom, sister, aunt or best friend. One out of eight women will get breast cancer in her lifetime. A small subset of the women who get ...
Learn how Mayo Clinic's Division of Clinical Trials and Biostatistics provides high-value analytical collaborations and research services to investigators.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.